NextBioMedical Co Ltd
KOSDAQ:389650
Cash Flow Statement
Cash Flow Statement
NextBioMedical Co Ltd
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
1 537
|
(118)
|
|
| Depreciation & Amortization |
741
|
521
|
|
| Stock-Based Compensation |
241
|
355
|
|
| Other Non-Cash Items |
(2 840)
|
181
|
|
| Cash Taxes Paid |
1
|
99
|
|
| Cash Interest Paid |
866
|
539
|
|
| Change in Working Capital |
(711)
|
(1 576)
|
|
| Cash from Operating Activities |
(1 273)
N/A
|
(992)
+22%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(2 734)
|
(3 092)
|
|
| Other Items |
(25 426)
|
909
|
|
| Cash from Investing Activities |
(28 160)
N/A
|
(2 183)
+92%
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
29 355
|
434
|
|
| Net Issuance of Debt |
26
|
(3 090)
|
|
| Cash from Financing Activities |
29 380
N/A
|
(2 656)
N/A
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
221
|
186
|
|
| Net Change in Cash |
168
N/A
|
(5 644)
N/A
|
|
| Free Cash Flow | |||
| Free Cash Flow |
(4 007)
N/A
|
(4 083)
-2%
|
|